UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

BMC neurology, 2011-05, Vol.11 (1), p.57-57, Article 57

2011

Volltextzugriff (PDF)

A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures

Epilepsia (Copenhagen), 2011-02, Vol.52 (2), p.234-242

2011

Volltextzugriff (PDF)

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Movement disorders, 2005-08, Vol.20 (8), p.932-936

2005

Volltextzugriff (PDF)

Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort

Pharmacology research & perspectives, 2020-12, Vol.8 (6), p.e00677-n/a

2020

Volltextzugriff (PDF)

Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects

Clinical therapeutics, 2011, Vol.33 (1), p.146-157

2011

Volltextzugriff (PDF)

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial

Neurology, 2015-09, Vol.85 (11), p.950-957

2015

Volltextzugriff (PDF)

Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, Demonstrates Superiority to Placebo for the Treatment of Chronic Immune Thrombocytopenic Purpura in a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Blood, 2017-12, Vol.130, p.17-17

2017

Volltextzugriff (PDF)

Striatal glutamatergic mechanisms and extrapyramidal movement disorders

Neurotoxicity research, 2003, Vol.5 (1-2), p.139-145

2003

Volltextzugriff (PDF)

Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553)

Neurology, 2021-04, Vol.96 (15_supplement)

2021

Volltextzugriff (PDF)

Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303

European journal of paediatric neurology, 2019-01, Vol.23 (1), p.126-135

2019

Volltextzugriff (PDF)

Secondary Screening of Patients in Randomized Perampanel Primary Generalized Tonic-Clonic Seizures (PGTCS) Study Excludes 29.9[percnt] of Eligible Patients Due to Inaccurate Classification (P2.045)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients

Journal of comparative effectiveness research, 2022-02, Vol.11 (3), p.139-155

2022

Volltextzugriff (PDF)

Efficacy and Safety of Adjunctive Rufinamide in Lennox-Gastaut Syndrome (LGS): Results from Studies 022, 022E, 303, 304, and 305 (P1.273)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Time to Pre-randomization Monthly Seizure Count for Perampanel in Patients with Primary Generalized Tonic-Clonic (PGTC) Seizures: A Potential New Clinical Endpoint (P1.270)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

Effect of Common Concomitant Antiepileptic Drugs (AEDs) During Adjunctive Treatment with Perampanel: Post Hoc Analysis from the Open-Label Extension (OLEx) of a Phase III Study in Patients with Idiopathic Generalized Epilepsy (IGE) (P1.261)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

055 Effect of common concomitant antiepileptic drugs during adjunctive treatment with perampanel: post hoc analysis from the open-label extension of a phase III study in patients with idiopathic generalised epilepsy

Journal of neurology, neurosurgery and psychiatry, 2018-06, Vol.89 (6), p.A23-A23

2018

Volltextzugriff (PDF)

Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double‐blind studies

Epilepsia (Copenhagen), 2017-01, Vol.58 (1), p.51-59

2017

Volltextzugriff (PDF)

Superiority of Avatrombopag to Placebo in Increasing Platelet Counts in Patients with Chronic Liver Disease-Associated Thrombocytopenia Undergoing Scheduled Procedures: Results from 2, Phase 3 Randomized Studies

Blood, 2017-12, Vol.130, p.18-18

2017

Volltextzugriff (PDF)

Dosing considerations for rufinamide in patients with Lennox–Gastaut syndrome: Phase III trial results and real-world clinical data

Seizure (London, England), 2017-04, Vol.47, p.25-33

2017

Volltextzugriff (PDF)

Effect of adjunctive perampanel on myoclonic and absence seizures: post-hoc analysis of data from the Extension Phase of a Phase III study in patients with idiopathic generalized epilepsy (IGE) (P3.236)

Neurology, 2017-04, Vol.88 (16_supplement)

2017

Volltextzugriff (PDF)

Assessment of the Long-Term Efficacy and Safety of Adjunctive Perampanel in Adolescent Patients: Post Hoc Analysis of Open-Label Extension (OLEx) Studies (P1.268)

Neurology, 2018-04, Vol.90 (15_supplement)

2018

Volltextzugriff (PDF)

PSYCHIATRIC/BEHAVIOURAL EVENTS WITH PERAMPANEL TREATMENT FOR PGTCS

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1

2016

Volltextzugriff (PDF)

PERAMPANEL TREATMENT FOR GENERALISED TONIC-CLONIC SEIZURES

Journal of neurology, neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1

2016

Volltextzugriff (PDF)

PO044 Long-term perampanel use in open-label extension studies

Journal of neurology, neurosurgery and psychiatry, 2017-12, Vol.88 (Suppl 1), p.A23-A23

2017

Volltextzugriff (PDF)

Efficacy of Adjunctive Perampanel in Idiopathic Generalized Epilepsy Patients with Drug-Resistant Primary Generalized Tonic-Clonic Seizures by Age, Sex, and Race: Double-Blind Placebo-Controlled Phase III Study (P2.021)

Neurology, 2016-04, Vol.86 (16_supplement)

2016

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(43)
Buchkapitel
(1)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer's disease

A randomized, double‐blind, placebo‐controlled, parallel‐group study of rufinamide as adjunctive therapy for refractory partial‐onset seizures

Effects of serotonin 5-HT1A agonist in advanced Parkinson's disease

Metabolite V, an epoxide species is a minor circulating metabolite in humans following a single oral dose of deflazacort

Bioavailability of Three Rufinamide Oral Suspensions Compared With the Marketed 400-mg Tablet Formulation: Results From a Randomized-Sequence, Open-Label, Four-Period, Four-Sequence Crossover Study in Healthy Subjects

Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy A randomized trial

Avatrombopag, a Novel Oral Thrombopoietin Receptor Agonist, Demonstrates Superiority to Placebo for the Treatment of Chronic Immune Thrombocytopenic Purpura in a Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Striatal glutamatergic mechanisms and extrapyramidal movement disorders

Ataluren Delays Loss of Ambulation and Decline in Pulmonary Function in Patients with Nonsense Mutation Duchenne Muscular Dystrophy (2553)

Evaluation of long-term safety, tolerability, and behavioral outcomes with adjunctive rufinamide in pediatric patients (≥1 to <4 years old) with Lennox-Gastaut syndrome: Final results from randomized study 303

Secondary Screening of Patients in Randomized Perampanel Primary Generalized Tonic-Clonic Seizures (PGTCS) Study Excludes 29.9[percnt] of Eligible Patients Due to Inaccurate Classification (P2.045)

Ataluren delays loss of ambulation and respiratory decline in nonsense mutation Duchenne muscular dystrophy patients

Efficacy and Safety of Adjunctive Rufinamide in Lennox-Gastaut Syndrome (LGS): Results from Studies 022, 022E, 303, 304, and 305 (P1.273)

Time to Pre-randomization Monthly Seizure Count for Perampanel in Patients with Primary Generalized Tonic-Clonic (PGTC) Seizures: A Potential New Clinical Endpoint (P1.270)

Effect of Common Concomitant Antiepileptic Drugs (AEDs) During Adjunctive Treatment with Perampanel: Post Hoc Analysis from the Open-Label Extension (OLEx) of a Phase III Study in Patients with Idiopathic Generalized Epilepsy (IGE) (P1.261)

055 Effect of common concomitant antiepileptic drugs during adjunctive treatment with perampanel: post hoc analysis from the open-label extension of a phase III study in patients with idiopathic generalised epilepsy

Analysis of falls in patients with epilepsy enrolled in the perampanel phase III randomized double‐blind studies

Superiority of Avatrombopag to Placebo in Increasing Platelet Counts in Patients with Chronic Liver Disease-Associated Thrombocytopenia Undergoing Scheduled Procedures: Results from 2, Phase 3 Randomized Studies

Dosing considerations for rufinamide in patients with Lennox–Gastaut syndrome: Phase III trial results and real-world clinical data

Effect of adjunctive perampanel on myoclonic and absence seizures: post-hoc analysis of data from the Extension Phase of a Phase III study in patients with idiopathic generalized epilepsy (IGE) (P3.236)

Assessment of the Long-Term Efficacy and Safety of Adjunctive Perampanel in Adolescent Patients: Post Hoc Analysis of Open-Label Extension (OLEx) Studies (P1.268)

PSYCHIATRIC/BEHAVIOURAL EVENTS WITH PERAMPANEL TREATMENT FOR PGTCS

PERAMPANEL TREATMENT FOR GENERALISED TONIC-CLONIC SEIZURES

PO044 Long-term perampanel use in open-label extension studies

Efficacy of Adjunctive Perampanel in Idiopathic Generalized Epilepsy Patients with Drug-Resistant Primary Generalized Tonic-Clonic Seizures by Age, Sex, and Race: Double-Blind Placebo-Controlled Phase III Study (P2.021)

Suchergebnisse filtern